GoldN Ebola Antigen Test program
Communitiesat the center.
An antigen test program for governments, NGOs and distributors who plan and respond to Ebola disease.
WHO context
Rare, severe, and shaped by early action.
~50%
average case fatality rate, varying from 25 to 90% in past outbreaks.
Community engagement is key to controlling outbreaks.
Early supportive care with rehydration and symptom treatment improves survival.
Source: World Health Organization, Ebola disease fact sheet and Ebola health topic page.
The program
What it covers, plainly.
- The test
- The GoldN Ebola Antigen Test.
- Related research
- Research and development on Marburg, a virus in the same family as the viruses that cause Ebola disease.
- Who it is for
- Governments, NGOs and distributors.
- Availability
- Not for sale in the United States.
Preparedness starts with a conversation.
Reach our Africa Initiatives team to talk about the program.